More Technology Does Not Always Mean Better Odds
In fertility care, innovation moves fast, and that is mostly a good thing. New tests, new lab techniques, new protocols. But faster and newer is not automatically safer or more effective, and the gap between "available" and "proven" is where a lot of families quietly overspend. This is a place to be a thoughtful, informed consumer, and that starts with knowing what the evidence actually says.
The rise of the add-on menu
Most clinics now offer a menu of extras alongside standard IVF, often framed as ways to boost your odds: advanced embryo testing, time-lapse imaging, assisted hatching, endometrial scratching, immune therapies, embryo glue. Some have a legitimate role for specific patients. Many do not have strong evidence behind them for the average patient.
The clearest independent yardstick comes from the United Kingdom's fertility regulator, the HFEA, which runs a public "traffic light" rating of add-ons based on evidence. Green means more than one good-quality randomized trial shows it is effective and safe. As of its review, no add-on had earned a green rating. None. (Reproductive BioMedicine Online30392-8/fulltext)) That single fact reframes the entire conversation.
A few specifics, because they matter:
- Endometrial scratching. A randomized controlled trial of 1,364 women published in the New England Journal of Medicine found it did not increase live births. It was nonetheless used in a substantial share of cycles. (STAT News)
- PGT-A (genetic testing of embryos). A large randomized trial and subsequent analysis found it makes no difference to live birth rates for many patients, and that abandoning embryos based on a single abnormal-cell reading may have cost some families viable embryos. (STAT News) It has real value for specific situations; it is not a universal upgrade.
- Assisted hatching and others. Rated red or amber by the HFEA, meaning evidence is absent or conflicting. (Reproductive BioMedicine Online30392-8/fulltext))
To be fair and accurate: some experts argue certain add-ons like time-lapse imaging and PGT-A have legitimate roles in selected patients and that narrow trials can understate their value. (Journal of IVF-Worldwide) The honest takeaway is not "never," it is "not by default, and not for everyone."
Families Out Loud brings honest, jargon-free family-building education to six cities in 2026 — with the experts in the room to answer your questions. One $40 weekend ticket.
Why families say yes anyway
We understand the pull completely. When you are emotionally and financially invested, declining something that might help feels reckless. Nobody wants to look back and wonder "what if we had done more?" We felt that exact pressure. The piece usually missing from the conversation is balance: What does the data show for someone like me? Who actually benefits from this? What does it cost, and what are the tradeoffs? Without that context, "consent" is not really informed.
Thoughtful care is not minimal care
Choosing fewer interventions is not settling. It is aligning your treatment with evidence, your values, and the outcome you actually want, which is a healthy baby and a healthy you, not a longer invoice. The questions we coach families to ask their clinic: Is this recommended because it is likely to help me specifically, or because it is offered here? What happens if I skip it? What does success look like beyond a positive test?
A good, ethical clinic answers those without defensiveness, and the best ones raise them before you have to. That willingness to have the honest conversation is exactly what we screen for in the providers we bring into a Families Out Loud room. Sometimes the most advanced choice in the room is restraint.
Families Out Loud is a nonprofit family-building community and traveling conference, founded by Mike Snaric and George Moore out of their own family-building journey. We make the path to parenthood safer, clearer, and more humane.
